PLOS one publication
 /  News / PLOS one publication

PLOS one publication

Stemina Biomarker Discovery, Inc. today announced the publication of research conducted in collaboration with the MIND Institute at the University of California-Davis to identify biomarkers in the blood of children with autism spectrum disorders (ASD) that can distinguish them from typically developing children. The research is the first of its kind and has the potential to enable earlier diagnosis and treatment of children with ASD from a blood sample.

Read the publication

Related Posts

(608) 204-0104

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com